Eisler Capital (UK)’s Thermo Fisher Scientific TMO Stock Holding History

Eisler Capital (UK)’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$84.7M	Buy	136,915 +5,633	+4%	+$3.33M	0.39%	56
2024 Q2	$72.6M	Buy	131,282 +64,693	+97%	+$37.1M	0.47%	51
2024 Q1	$38.7M	Buy	66,589 +3,922	+6%	+$2.2M	0.32%	77
2023 Q4	$33.3M	Buy	62,667 +642	+1%	+$311K	0.26%	89
2023 Q3	$31.4M	Buy	62,025 +26,425	+74%	+$14.1M	0.2%	109
2023 Q2	$18.6M	Sell	35,600 -78,200	-69%	-$42.2M	0.13%	141
2023 Q1	$65.6M	Buy	+113,800	New	+$64.1M	0.65%	31
2022 Q2	–	Sell	-78,400	Closed	-$46.3M	–	520
2022 Q1	$46.3M	Buy	+78,400	New	+$45M	0.78%	30

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Eisler Capital (UK)'s TMO Position: Q3 2024 in Review

Eisler Capital (UK) reduced its Thermo Fisher Scientific (TMO) stake by 91% in Q3 2024, selling an estimated $4.08M and leaving 703 shares worth $435K. The position accounts for ﹤0.01% of the portfolio, ranked #537.

Eisler Capital (UK) first reported a position in TMO in Q1 2022 and has held it in 7 quarters since. The position peaked at $8.75M in Q3 2023. 2,568 funds tracked by Wall St. Rank hold TMO as of Q3 2024.

Eisler Capital (UK) held 703 shares of Thermo Fisher Scientific worth $435K as of Q3 2024.
Eisler Capital (UK) sold 6,887 Thermo Fisher Scientific shares in Q3 2024, an estimated $4.08M.
Thermo Fisher Scientific made up ﹤0.01% of Eisler Capital (UK)'s portfolio in Q3 2024, its #537 holding.
Eisler Capital (UK) first reported a position in Thermo Fisher Scientific in Q1 2022 and has held it in 7 quarters since.
Eisler Capital (UK)'s Thermo Fisher Scientific position peaked at $8.75M in Q3 2023.
2,568 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2024.

Based on Eisler Capital (UK)'s 13F filing for Q3 2024, filed 14 Nov 2024.